Welcome to Nofinity

New Paradigm: Microglia as the Key to Brain Health

• Old Model: Alzheimer's is caused by the accumulation of the protein beta-amyloid. Drugs to remove this protein proved ineffective.
• New Insight: The real 'villains' are the microglia, the brain's immune cells. They can be either protective (M2) or destructive (M1).
• The switch from protective to harmful microglia is determined by your overall metabolic health – particularly blood sugar, inflammation, and other factors.

Threats to the Brain: Driving the Switch to Harmful Microglia

• High Blood Sugar & Insulin Resistance: Even an HbA1c above 5.8% or a fasting blood sugar over 90 mg/dL (5.0 mmol/L) is dangerous, as it pushes microglia into the M1 state. Type 2 diabetes triples the risk of Alzheimer's.
• Inflammation: Inflammatory chemicals (cytokines) travel from anywhere in the body to the brain, driving the harmful transformation of microglia.
• Environmental Toxins: Fine particulate matter (PM2.5), microplastics, and other pollutants irritate the immune system and promote neuroinflammation.
• Certain Medications: Chronic use of NSAIDs (e.g., ibuprofen) and proton pump inhibitors (acid blockers) can harm the gut, increase inflammation, and indirectly affect microglia.

1. Optimize Your Metabolism: * Lower Blood Sugar: Aim for a fasting blood sugar below 90 mg/dL (5.0 mmol/L) and an HbA1c below 5.8%. Use a continuous glucose monitor (CGM) to understand how your body reacts to food, sleep, stress, and exercise. Fasting insulin is a much earlier warning sign. * Adjust Your Diet: * Avoid ultra-processed foods and simple sugars. * Focus on a high-fiber, plant-forward diet to feed your gut microbiome. * Incorporate polyphenols from sources like extra virgin olive oil. * Consider time-restricted eating (fasting) or a ketogenic diet to support the mitochondrial function of microglia.

2. Lifestyle as Medicine: * Exercise (Top Priority): A combination of aerobic and resistance training is best. Exercise releases myokines that increase BDNF (brain-derived neurotrophic factor), a protein that promotes the growth of new brain cells and synapses. Muscles are endocrine glands. Stretching (e.g., yoga) is crucial to prevent injury and maintain your exercise routine. * Sleep: 7-9 hours with sufficient deep sleep is non-negotiable. The brain cleans itself during deep sleep. Use a wearable (e.g., Oura Ring or Apple Watch) to track sleep quality. * Heat (Sauna) and Cold Exposure: Activate heat shock proteins, which reduce inflammation and combat protein misfolding in the brain.

3. Supplementation (as Support): * Basics: Fish oil (Omega-3s), Vitamin D, a probiotic, B-complex, Vitamin K2, Magnesium. * Specialized: Coenzyme Q10, Creatine Monohydrate, Urolithin A, and Rosmarinic Acid(rosemary) to support mitochondrial health and reduce inflammation.

• Alzheimer's is treatable and reversible. Studies (e.g., by Dr. Rudolph Tanzi/Harvard) show that lifestyle changes can lead to stabilization and even some regained function.
• It is never too early or too late to start this protocol. Even after symptoms appear (subjective cognitive impairment, MCI), interventions can still be effective.
• Prevention is the best medicine. Don't wait for the fire; 'fix the roof while the sun is shining.'

Protect your memory by keeping your microglia on your side. You can achieve this through stable blood sugar (< 90 mg/dL fasting), an anti-inflammatory, high-fiber diet, daily exercise (especially strength and cardio), quality sleep, and avoiding environmental toxins. This lifestyle is your daily protocol for a healthy brain.

This video demonstrates how to build an AI trading bot that mimics Warren Buffett's investment strategy, using the open-source "AI Hedge Fund" project on GitHub. The bot leverages Claude (Fable 5.1) and real-time financial data (e.g., from Financial Datasets) to analyze stocks and execute trades.

Key Steps & Results:

• Stock Analysis: The AI Buffett rated Apple as neutral (60% confidence) and Nvidia cautiously (due to margin concerns). Coca-Cola received the highest confidence (68%).
• Portfolio Construction: With a simulated $100,000 fund, the bot selected 24 stocks from the S&P 500 top 100. Top holding: Microsoft; smallest: IBM. Only 3% cash.
• Backtest (Sept. 2024 to present): The AI Buffett outperformed the S&P 500 with a return of 39.2% vs. 34.8% and a lower max drawdown (5.8% vs. 8%). Best performer: Alphabet (+114%); worst: Accenture (-$2,000).
• Automation: The bot can be connected to an Alpaca paper trading account via API for automatic order execution. Persistent operation on a VPS is supported.

Conclusion:

The simulation suggests an AI model based on Buffett's approach can beat the market — at least in backtesting. However, the creator warns against entrusting real savings to such a bot. The project is intended as an experiment and learning tool.

Summary follows...

The 2 Amino Acids That Restore Muscle Strength & Burn 78% More Fat

This summary analyzes a study on GlyNAC (Glycine + N-Acetylcysteine) and its effects on mitochondrial health, muscle strength, and fat metabolism in older adults.

• Mitochondrial Dysfunction: Aging muscle cells lose the ability to efficiently burn fatty acids.
• Glutathione Deficiency: Intracellular glutathione, the cell's master antioxidant, is reduced by up to 70% in older adults.
• Root Cause: Two rate-limiting building blocks – glycine and cysteine – are equally depleted with age.

• Mechanism: The cell needs both amino acids to produce glutathione. Glycine and NAC provide the missing components.
• Study Design: 24 overweight older adults (61-80 years) received 100 mg/kg glycine + 100 mg/kg NAC daily (approximately 9 g per amino acid for a 90 kg person) for 16 weeks.

• Glutathione Increase: +225% in red blood cells, +164% in muscle biopsies – reaching levels of young adults.
• Fat Oxidation: +78% increase.
• Muscle Strength:
  • Gait Speed: +0.21 m/s (matching young adult levels)
  • Grip Strength: +4.4 kg (dominant hand)
  • Chair Rise Test: -6.8 seconds (better leg power)
• No Muscle Gain: Lean mass remained unchanged. Strength gains resulted from improved mitochondrial efficiency.

• Anti-Inflammatory: Interleukin-6 decreased by 78%, TNF-alpha by 54%, protective interleukin-10 nearly doubled.
• Insulin Resistance: HOMA-IR decreased by 64%.
• Oxidative Stress: DNA damage markers dropped by 73%.
• Blood Pressure: Systolic decreased from 132 to 124 mmHg.

• High Dosage: The study used very high doses (18 g of amino acids daily). Lower doses have not been tested.
• No Sustained Effect: After stopping GlyNAC, glutathione levels and strength gains returned to baseline.
• Lifespan Extension: The often-cited 24% lifespan increase comes from a mouse study, not human data.

GlyNAC addresses a core cause of age-related strength and energy loss: glutathione deficiency. The results are promising but require medical supervision, especially at high doses and regarding potential drug interactions.

• A 49-year-old sets the ambitious goal to dunk a basketball – a symbol of youthful athleticism and vitality.
• He trains with a professional coach who works with NBA players and has been at it for nearly 3 months.

• Instead of abstract metrics like VO2max (which he previously pushed to elite 18-year-old levels), he now focuses on a visible, relatable target.
• A dunk resonates with people: „The best biomarker I could ever achieve.“

• Phase 1 (first 2 months): Build a strong physiological base – especially tendon health and stiffness (tendons adapt in 8–12 weeks, muscles in 3–4).
• Phase 2 (from month 3): Add strength (for force production) and later speed (rate of force development).
• Current vertical jump measurement: 23.9 inches (approx. 60.7 cm) – baseline.

• After 3 months he feels clear gains and more trust in his body.
• The coach estimates an 80–85% success probability – aided by lean physique, good nutrition and sleep.
• Key: precise execution of drills (e.g., knees over toes in squats, bouncy movements).

„It‘s not about stopping the negative, it‘s about doing the positive.“ – The journey to a dunk is a statement against age limits.

• Clarity Act Fails: The first major US crypto regulation bill died in the Senate (49:50, 10 votes short). Coinbase stock fell 8%, Circle ~10%. Bitcoin ignored it.
• Fed Rate Hike: The US Federal Reserve raised rates by 25 basis points (first since 2023). The 10-year Treasury yield spiked above 5%, the Bank of Japan hiked to a 31-year high. Bitcoin still rose.
• AI Sector Weakens: Anthropic's CEO warned about runaway AI progress. Sam Altman and Elon Musk agreed. The semiconductor index dropped over 5%; Nvidia, ASML, SoftBank all fell. Crypto remained unfazed.

• 84% of liquidations were shorts ($843M of $1B total).
• In a single hour, over $300M was liquidated, 97% of it shorts.
• Between 126,000 and 135,000 accounts were closed.
• One wallet lost 375 BTC (~$32.5M) in four sequential liquidations over 14 hours.
• Mechanics: Forced buying from short liquidations pushes price higher → triggers next layer of shorts → cascade.

• Clarity Act irrelevant for markets: A failed bill changes nothing about Bitcoin's functionality (blocks, trades, custody). Crypto grew to over $1 trillion without US regulation.
• Institutions keep buying:
  • Strategy (MicroStrategy) bought 950 BTC for $75M right in the worst news week.
  • US spot Bitcoin ETFs lost $450M on voting day, but regained $433M just three sessions later.
  • Morgan Stanley's Bitcoin ETF logged 20 consecutive days of net inflows.

• China ban 2021: >50% of global hashrate went offline → Bitcoin rose from $29K to new ATH in 4 months.
• FTX collapse Nov 2022: Low of $15,400 – the absolute bottom.
• US banking crisis March 2023: Three banks failed, USDC depegged → Bitcoin rallied 40%.
• Inverse: Coinbase IPO April 2021 (peak) and ETF approval January 2024 (price fell from 49K to 38K) – good news marked tops.

Bitcoin is not a market that only rises on good news. The current rally through three parallel shocks shows: A strong holder base and institutional demand drive price independently of politics and macro. Future headlines may be just as grim – but crypto has proven itself through years of uncertainty and hostility. The question: Higher from here, or a bull trap?

Kaspi.kz (NASDAQ: KSPI) is a super app from Kazakhstan that covers nearly the entire financial and daily life of the country. The stock offers a dividend yield of almost 9 %, a P/E ratio of about 7, and growth of around 17 % – for the analyst, it's hard to find much wrong.

• Monopoly position: 85 % of payment processing and 70 % market share in consumer commerce in Kazakhstan.
• Government integration: Deep cooperation with the government and central bank – considered “too big to fail.” After a short-seller report (Culper Research), regulators immediately defended the company.
• Super app: Used for healthcare, government services, and banking – practically the entire population depends on it.
• Monopoly with political backing: This only works in Kazakhstan, but there it is a legal money-printing machine.

• Acquisition of Turkish e-commerce leader Hepsiburada for $1.1 billion.
• Acquisition of a banking license (Rabobank license) and planned capital injection of $300 million.
• Expansion of a “Buy Now, Pay Later” business and integration of fintech solutions into the Turkish platform.
• If Turkish profitability even approaches Kazakh levels, this could become a major winner.

• Net income is growing, stable net margin of around 27 %.
• E-commerce growth and payment business are strong thanks to the monopoly position.
• Non-performing loans (NPL): About 6–7 % and slightly rising – worth watching, but cushioned by high interest rates (15 % central bank rate).
• Balance sheet: $15 billion in customer loans, $17 billion in customer deposits – typical bank risks, but with fintech margins.

• Kazakhstan risk: Political connections, corruption allegations, possible rumors about bank stability.
• Dependence on the state: If political support changes, the business model would be in danger.
• Currency risk: Tenge fluctuations, but growth remains strong when measured in dollars.
• Bank risk: As a financial company, always vulnerable to loss of confidence and potential bank runs.

• P/E of 8 with 15 % growth and an 8–9 % dividend yield provide a margin of safety.
• Tencent as an investor and the “Silk Belt and Road” connection to China are additional strategic pluses.
• Founders own 66 % of the capital – without them the construct would not work, which creates resilience.
• The analyst is considering adding the stock to his diversified portfolio, although he considers the environment risky. “Hard to find much wrong” – but it remains an engaged emerging-market investment.